Skip to main content
Fig. 4 | BMC Endocrine Disorders

Fig. 4

From: Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma

Fig. 4

TMB cannot affect ACC immune microenvironment. A The landscape of immune abundance of 22 leukocyte subtypes in each ACC sample. B Comparison of the infiltrating levels of 22 immune cells between different TMB groups. Green means low-TMB group; Red means high-TMB group. C Comparison of the activity scores of 13 immune-related pathways between different TMB groups. D The effects of six key immune cells on ACC prognosis

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us